Volume: 25 Issue: 2

1. Statistical consideration in the design of COVID-19 clinical trials in emergency Page:121—125
2. New use of old drugs in the treatment of SARS-CoV-2 infection Page:126—134
3. Analysis of clinical trial registration information of COVID-19 in China Page:135—140
4. New coronavirus pneumonia: Question and confusion Page:141—143
5. PROfound: A new hope for precise treatment of prostate cancer Page:144—150
6. Effect of JiSuiKang on the microglia infiltration and neuron survival in the spinal cord injury area of rats Page:151—158
7. Endoplasmic reticulum stress-induced apoptosis up-regulation of DR5 via a CHOP-dependent mechanism in HSC-T6 cells Page:159—166
8. Role and mechanism of platelet-derived growth factor/AKT pathway in pressure overload-induced ventricular remodeling Page:167—173
9. Resveratrol inhibits the proliferation of retinoblastoma cells via miR-937/FOXQ1 pathway Page:174—181
10. CNR1 genetic variation influences the clinical outcomes of early stage type 2 diabetes mellitus treated with liraglutide Page:182—188
11. Efficacy and safety of etoposide combined with carboplatin in children with recurrent medulloblastoma Page:189—195
12. Qilin pills prevent ovarian hyperstimulation syndrome of patients after IVF-ET by regulating plasma-related indicators Page:196—202
13. Distribution and drug resistance of bacterial pathogens in the infecting inpatients of department of nephrology Page:203—208
14. Clinical characteristics of insulin autoimmune syndrome caused by methimazole in Chinese population Page:209—213
15. Regulation of REM sleep: Basic mechanisms and clinical drugs Page:214—220
16. Advances of the clinical pharmacology of hydroxychloroquine sulfate Page:221—226
17. A surey of bioanalysis methods for antibody drugs Page:227—232
18. Research progress in pharmacological effects and clinical applications of ebselen Page:233—240